diseases Flashcards

1
Q

HEALTH

A

A state of mental, physical and social wellbeing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DISEASE

A

Poor state of mental, physical and social well-being or an abnormal
condition affecting an organism that reduces the effectiveness or function of that organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

INFECTIOUS DISEASES [communicable diseases]

A

A disease caused by a pathogen
that spreads from one person to another. E.g., HIV, cholera, common cold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PATHOGEN

A

an organism that causes disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Transmission

A

the transfer of a pathogen from a person infected with
that pathogen to an uninfected person; transmission may occur by direct contact, through the air or water, or by animal vectors, such as insect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DISEASE CARRIER / CARRIER

A

a person infected with a pathogen who shows no
symptoms, but can be the source of infection in other people [not carrier of inherited diseases]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TRANSMISSION CYCLE

A

the passage of a pathogen from one host to another is
continually repeated as the pathogen infects new hosts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

disease eradication

A

the complete breakage of the transmission cycle of a
pathogen so that there are no cases of the disease caused by the pathogen anywhere in the world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ENDEMIC DISEASES

A

a disease that is always in a population [e.g. TB,
malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

. INCIDENCE

A

the incidence of a disease is the number of people who are
diagnosed over a certain period of time, usually a week, month or a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PREVALENCE

A

the prevalence of a disease is the number of people who have
that disease at any one time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EPIDEMIC

A

an epidemic occurs when there is a sudden increase in the
number of people with a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PANDEMIC

A

a pandemic occurs when there is an increase in the number
of cases throughout a continent or across the world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MORTALITY RATE

A

the number of deaths over a particular length of
time (usually a year) is the mortality rate [usually shown as “per 100,000
people”]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NATALITY

A

birth rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NON-INFECTIOUS DISEASE

A

Not caused by a pathogen. Does not spread from one person to another. E.g., sickle cell anemia and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ACUTE

A

comes out suddenly and rapidly and lasts for a short time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CHRONIC

A

progressive disease that lasts for a long tim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

INCUBATION PERIOD

A

The incubation period is the time taken for an
infection to develop after a person has been exposed to a disease-causing organism (such as bacteria, viruses, or fungi). The incubation period ends when the first signs or symptoms of the disease appear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

cholera name of pathogen

A

Vibrio cholerae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cholera type of pathogen

A

Bacterium
[prokaryote]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

malaria pathogen

A

Four species of plasmodium:
1. Plasmodium falciparum
2. Plasmodium malariae
3. Plasmodium ovale
4. Plasmodium vivax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

malaria type of pathogen

A

Protoctist [eukaryote]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HIV/ AIDS pathogen

A

Human immunodeficiency virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

HIV/AIDS types of pathogen

A

Virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

TB pathogen

A
  1. Mycobacterium tuberculosis
  2. Mycobacterium bovis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

TB types of pathogen

A

Bacterium
[prokaryote]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

cholera methods of transmission

A

food-borne, water-borne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Global distrbution of cholera

A

Asia, Africa, Latin America

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

cholera incubation period

A

two hours to five days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

site of action of pathogens for cholera

A

wall of small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

clinical features of cholera

A

severe diarrhoea (‘rice water’), loss of water and
salts, dehydration, weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

method of diagnosis cholera

A

dipstick test rectal swabs; identification of
V.cholerae in faecal samples using microscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

To reach the site of infection [wall of small intestine

A

the bacteria have to pass through the stomach. If the contents are sufficiently acidic [pH less than 4.5], the bacteria are unlikely to survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

ACTION IN THE SMALL INTESTINE

A
  • after reaching small intestine, they multiply and secrete the toxin [named choleragen]
  • this toxin disrupts the functions of the epithelium lining, so that salts water leave the blood
  • the loss of salts and water causes severe diarrhoea
  • loss of fluid can be fatal if not treated within 24 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

As Vibrio cholerae reaches the small intestine lumen

A

it releases a toxin named choleragen / enterotoxin. It is a quaternary protein made up of 6 polypeptide chains. It has 2 subunits, subunit A [1 polypeptide] and subunit B [5 polypeptide]Choleragen makes a complementary binding with ganglioside receptor/GM1 in the
small intestine epithelial cell [hydrogen or ionic bond] [NOTE: subunit B makes complementary binding with GM1]
* membrane pinches in or invaginates to form endocytotic vacuole - ENDOCYTOSIS
* choleragen gets transported to the ER
* altered Subunit A is released from ER
* A subunit activates the G-protein and enzyme adenylate cyclase that leads to an increase in the concentration of cAMP [cyclic adenosine monophosphate], a second messenger which initiates a cascade of chemical reactions within the cell
* As a response, Clchannels open and leads to the efflux of ions into the lumen decreasing the water potential, so water comes out of cells to the lumen by osmosis
* This leads to severe diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Oral rehydration therapy

A
  • Water for rehydration
  • Glucose to provide energy for active uptake of ions
  • Na+ ions to replace lost ions, lowers water potential of epithelial cells
  • K+ ions to replace lost ions and stimulate appetite
  • Other electrolyte to prevent electrolyte imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Problems involved in preventing the spread of cholera

A
  • Poor sanitation / no treatment of faecal matter
  • Contamination of drinking water supply
  • Poverty / poor living condition
  • Poor hygiene
  • Contamination of vegetable plots with faecal matter
  • Poor/ lack of health education about transmission
  • Natural disaster, refuges, no effective vaccine
  • Lack of water purification equipment or bottled water
  • No rehydration therapy at time when needed
  • Bacteria live in gut where immune system is not very
    effective. [antigenic concealment]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Why is cholera not common in developed countries?

A
  • Transmission cycle is broken
  • Better sewage treatment plant
  • Human faeces don’t come in contact with drinking water supply.
  • Water is treated with chlorine to kill bacteria
  • Drinking water clean piped at home
  • Good sewage dispersal
  • Good health services
  • No residents are homeless
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Why cholera is more common after a natural disaster?

A

 Increased number of people / lack of infrastructure
 Problem in providing safe drinking water
 Faeces / sewage mixed with drinking water
 Poor sanitation
 Unable to practice good hygiene
 Infected people share same latrines with uninfected
 Lack of proper medical care/ drugs/ antibiotics/ skilled person/ ORT
 Unable to supply sufficient vaccine
 Lack of food/ poor diet so vaccine is not effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Cholera vaccine is used for

A

active immunization against cholera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Use of cholera vaccine does not prevent

A

transmission of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Reasons why vaccination has not eradicated cholera

A

1 transmission cycle is difficult to break;
2 difficulty in administering e.g. refugee camp, displaced, disaster;
3 poor diet, lowered immune response;
4 more than one strain (needs more than one type of vaccine);
5 vaccine, only gives short-term protection / requiring boosters;
6 antigenic concealment - live beyond the reach of antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

malaria pathogen

A

Plasmodium falciparum, P. vivax, P. ovale, P. malariae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

malaria methods of transmission

A

Insect vector: female Anopheles mosquito [about 30 different
species]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

malaria global distribution

A

throughout the tropics and sub-tropics (endemic in 106 countries)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

malaria incubation period

A

from a week to a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

malaria site of action of pathogen

A

liver, red blood cells, brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

malaria clinical features

A

fever, anaemia, nausea, headaches, muscle pain, shivering,
sweating, enlarged spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

malaria methods of diagnosis

A

microscopical examination of blood; dip stick test for malaria
antigens in blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Why only female Anopheles feed on human blood?

A

Female Anopheles mosquitoes feed on human blood
to obtain the protein they need to develop their
eggs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Gametocyte:

A

a cell (as of a protozoan causing malaria) that
divides to produce gametes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

SPOROZOITES

A

the infective mature stage of plasmodium seen in the gut and salivary glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

The life cycle of Plasmodium

A
  • The parasite has two hosts: the sexual stage occurs in
    mosquitoes, the asexual stage in humans
  • The time between infection and appearance of parasites inside red blood cells is 7–30 days in P. falciparum; longer in other species.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

All cases of suspected malaria should be confirmed by

A

using microscopical examination of blood before treatment is started [result available in 30 minutes]

58
Q

Treating malaria

A
  • Anti-malarial drugs like quinine [an extract from cinchona tree]and chloroquinine are used to treat infected people
  • Newer drug - Mefloquine –has side effects like dizziness, vomiting [The antimalarial Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis.]
  • Mefloquine resistance seen in S. E. Asia
  • Artemisinin based combination therapy [ACT]- Artimisia plant extract + mefloquine is the best treatment at present [Artemisinin enhances efficacy and has the potential of lowering the rate at which resistance emerges and spreads.]
59
Q

Prophylactic drugs [preventive drugs] are

A

❑ Chloroquine – inhibits protein synthesis thus prevents spreading with in the body
❑ Proguanil – prevents sexual reproduction of plasmodium within mosquitoes
* Prophylactic drugs has to be taken before going to countries endemic to malaria

60
Q

Where anti-malarial drugs have been used widely,

A

drug-resistant Plasmodium are also seen
* Chloroquine resistance widespread in parts of S. America, Africa and S. E. Asia

61
Q

Preventing Malaria
ABCD method

A

A- Awareness
B- Bite control
C- Control of mosquitoes
D- Diagnosis and drugs

62
Q

B- Bite control

A

use of repellent creams, sprays, mosquito coil, using mosquito nets, mesh on windows and doors, covering body from head to toes

63
Q

C- Control of mosquitoes

A
  • by adding oil on the surface of still water to break the oxygen supply.
    Spray insecticides, drain water from unused things like trees, pots etc.
  • biological control method - use the normal predators of mosquitoes:
    ❑ stocking ponds, irrigation and drainage ditches and other permanent
    bodies of water with fish which feed on mosquito larvae
    ❑ spraying a preparation containing the bacterium Bacillus thuringiensis which kills mosquito larvae but is not toxic to other forms of life
64
Q

D- Diagnosis and drug

A
  • Diagnosis by blood test.
  • Quinine is the drug used against malaria extracted from the bark of
    cinchona.
  • The whole genome of Plasmodium has been sequenced, and this is leading to the
    development of new treatments and vaccines.
  • RTS,S / AS01(RTS,S) – also known as Mosquirix – is an injectable vaccine that provides
    partial protection against malaria in young children
65
Q

Describe the factors that may lead to improvements in the control of malaria?

A
  1. Use of modern techniques in gene sequencing and drug design
  2. Development of vaccines targeted against different stages of the parasite’s life cycle
  3. A renewed international will to remove the burden of malaria from the poorest parts of the world, allied to generous donations from wealthy individuals and foundations
66
Q

Reason behind worldwide spread of malaria

A
  • Migration of people/ tourism promotes spreading
  • Drug resistance in plasmodium
  • Mosquito resistance to insecticides
  • No vaccine available because of antigenic variability and antigenic concealment [some pathogens evade/escape attack by the immune system by living or hiding inside cells]
  • Lack of awareness
  • Global warming- suitable condition for plasmodium
  • Poverty in affected area
  • War and political unrest – preventing implementation of antimalarial programme
67
Q

Explain why it has been difficult to develop an effective vaccine for malaria

A
  • Plasmodium, has many genes as they are eukaryotes, so, many types of antigens.
  • It has many different stages of life cycle within human so antigens change in different stages and also antibodies cannot work against stages within cells [e.g. trophozoites]
  • More than one Plasmodium species;
  • Variation generated during meiosis
  • Parasite only vulnerable at certain stages of life cycle / when free in plasma - antigenic concealment.
68
Q

Describe how malaria is passed from an infected person to an
uninfected person

A

 female, Anopheles (mosquito) ; takes blood (meal) from an (infected) person, feeds on an
(uninfected) person ;
 Plasmodium / parasite, transmitted in (mosquito’s) saliva ;
 blood transfusion / shared needles / across placenta / at birth ;

69
Q

Why malaria is restricted to the tropics

A

1 Anopheles mosquito / vector, survives / breeds / lives, within the tropics / in hot andhumid areas ;
2 Plasmodium / pathogen / parasite, needs to reproduce within the mosquito (at temperatures above 20°C) ;
Mosquitoes need area of still water to complete its life cycle [High rainfall]
3. eradicated in areas outside tropics. E.g., North America

70
Q

HIV/AIDS methods of transmission

A
  • in semen and vaginal fluids during sexual intercourse
  • infected blood or blood products
  • contaminated hypodermic syringes
  • mother to fetus across placenta and at birth
  • mother to infant in breast milk
71
Q

HIV/AIDS global distrbution

A

worldwide, especially in sub-Saharan Africa and South-East Asia

72
Q

HIV/AIDS incubation period

A

Initial incubation – a few weeks
But upto ten years or more before symptoms of AIDS may develop

73
Q

HIV/AIDS site of action of pathogen

A

T helper lymphocytes, macrophages, brain cells

74
Q

HIV/AIDS clinical features

A

HIV infection – flu-like symptoms and then symptomless
AIDS – opportunistic infections including pneumonia, TB and
cancers; weight loss, diarrhoea, fever, sweating, dementia[loss of cognitive functioning — thinking, remembering, and reasoning]

75
Q

HIV/AIDS methods of diagnosis

A

testing blood, saliva or urine for the presence of antibodies produced
against HIV

76
Q

What is HIV?

A
  • H – Human – This particular virus can only infect human beings.
  • I – Immunodeficiency – HIV weakens your immune system by destroying important cells that fight disease and infection [helper T cells]. A “deficient” immune system can’t protect you.
  • V – Virus – A virus can only reproduce itself by taking over a cell in the body of its host
77
Q

Disease: AIDS – ACQUIRED IMMUNO DEFICIENCY SYNDROME

A
  • A – Acquired – AIDS is not something you inherit from your parents like eye color.
    You acquire AIDS.
  • I – Immuno – Your body’s immune system includes all the organs and cells that work to fight off infection or disease.
  • D – Deficiency – You get AIDS when your immune system is “deficient,” or isn’t working the way
    it should.
  • S – Syndrome – A syndrome is a collection of symptoms and signs of disease. AIDS is a syndrome, rather than a single disease. It is a complex illness with a wide range of symptoms.
78
Q

Human immunodeficiency virus (HIV) structure

A
  • The outer lipid membrane forms the envelope, which also has two
    glycoproteins: gp120 and gp41
  • The protein core contains genetic material (RNA) and has enzymes:
    protease, integrase and reverse transcriptase.
  • Reverse transcriptase uses the RNA as a template to produce DNA once the virus is inside a host cell
  • Integrase enzyme helps to integrate viral DNA with human nuclear DNA
79
Q
A
80
Q

VHIV is a retrovirus

A

Its genetic material is RNA, not DNA. Once inside the host cell [helper T cell / macrophage], the viral RNA is converted back to DNA [hence called ‘retro’]

81
Q
A
  • HIV binds to CD4 receptors on T-helper cells using glycoprotein gp120
  • Genetic material [RNA] and enzymes present in virus enter the cell
  • RNA gets converted to double stranded DNA. It undergoes reverse transcription inside the host cell with the help of reverse transcriptase enzyme [present inside the HIV]. It takes nucleotides from the cytoplasm of host cells. – many errors occur during this process
    leading to formation of new antigens
  • Viral DNA enters nucleus through nuclear pore.
  • It attaches to the DNA [in host cell nucleus] with the help of the enzyme integrase.
  • It undergoes transcription and a viral RNA is formed.
  • It undergoes translation to produce gp120, reverse transcriptase, integrase, protease and RNA molecules.
  • All this comes to the surface of T-helper cells and buds off as an active HIV
  • HIV infected T helper cells trigger self destruction mechanism
  • Reverse transcriptase makes mistakes during reverse transcription [develops resistance to drugs and hard to develop vaccine
82
Q
A
83
Q

Problems controlling spread of HIV

A
  • No cure / no vaccine;
  • Drugs are expensive.
  • Problems with symptomless carriers (spreading the virus);
  • Problems with testing people for HIV status;
  • Problems with providing, condoms/femidoms;
  • Problems with educating about risks;
  • Problems with tracing contacts (of infected people);
  • Problems with screening blood donations;
  • Problems with treating blood to kill HIV;
84
Q

Combat against HIV

A
  • testing people for HIV status;
  • providing, condoms/femidoms;
  • educating about risks;
  • tracing contacts (of infected people);
  • screening blood donations and treating blood to kill hiv
85
Q

High risk groups for AIDS

A
  • Male homosexuals
  • Prostitutes
  • People with multiple partners
  • Injected drug users
  • Haemophiliacs, who are injected with Factor 8 [essential blood-clotting protein] from the blood of several donors
86
Q

Treating HIV/AIDS

A
  • No vaccine or cure, but drugs can slow down its action:
  • zidovudine binds to reverse transcriptase and blocks its action
  • Combinations of drugs can significantly aid the slowing of AIDS but is expensive and has side effects.
87
Q

Tb pathogen

A

Mycobacterium tuberculosis; Mycobacterium bovis

88
Q

Tb methods of transmission

A

airborne droplets (M. tuberculosis); via undercooked meat and unpasteurized milk (M. bovis)

89
Q

Tb global distrbution

A

worldwide

90
Q

Tb incubation period

A

few weeks or up to several years

91
Q

Tb site of action of pathogen

A

primary infection in lungs; secondary infections in lymph
nodes, bones and gut

92
Q

Tb clinical features

A

wracking cough, coughing blood, chest pain, shortness of breath, fever,
sweating, weight loss

93
Q

Tb methods of diagnosis

A

Rapid molecular test detecting presence of DNA from M.tuberculosis;
microscopical examination of sputum for bacteria; chest X-ray; long-term culture of bacteria (up to 12 weeks)

94
Q

TRANSMISSION OF TUBERCULOSIS [TB]

A
  • inhalation of mycobacteria present in aerosol droplets
  • bacteria meet with alveolar macrophages
  • bacteria ingested by the macrophages, but they manage to survive inside
  • an inflammatory response gets triggered bringing other defensive cells to the area, forming a mass of tissue, called a granuloma [core of infected macrophages enclosed by other cells of the immune
    system]
  • macrophages loaded with bacteria are killed, resulting in the formation of the caseous center of the granuloma
95
Q

latent tuberculosis

A

bacteria become dormant and remain alive for decades without symptoms

96
Q

active pulmonary tuberculosis

A

infection stops in healthy people at this stage, but if the immune system is compromised by immunosuppressive drugs, HIV infections, malnutrition, aging, or other factors, the bacteria can be reactivated, replicate, escape from the granuloma and spread to other parts of the lungs causing, This reactivation may occur after months or even years after the initial infection

97
Q

In some cases, the bacteria may also spread to other organs of the body via the

A

lymphatic system or the bloodstream. This widespread form of TB disease, called disseminated TB or miliary TB, occurs most commonly in the very young, the very old and those with HIV infections.

98
Q

Tuberculosis is generally treatable with antibiotics

A

Several antibiotics are usually prescribed for many
months due to the slow growth rate of the bacteria. It’s very important that the patients complete the course of the treatment to prevent development of drug-resistant bacteria and re-occurrence of the
disease.

99
Q

TB transmission

A

An infection is initiated following inhalation of mycobacteria present in aerosol droplets discharged into the atmosphere by a person with an active infection.
* The transmission process is very efficient as these droplets can persist in the atmosphere for several hours and the infectious dose is very low – less than 10 bacilli are needed to start the infection.
* Once in the lung, the bacteria meet with the body’s first-line defense - the alveolar macrophages. The bacteria are ingested by the macrophages but manage to survive inside. Internalization of the bacilli triggers an inflammatory response that brings other defensive cells to the area. Together, these cells form a mass of tissue, called a granuloma, characteristic of the disease.

100
Q

TB early stages

A
  • In its early stage, the granuloma has a core of infected macrophages enclosed by other cells of the immune system. As cellular immunity develops, macrophages loaded with bacteria are killed, resulting in the formation of the caseous center of the granuloma.
  • The bacteria become dormant but may remain alive for decades. This enclosed infection is referred to as latent tuberculosis and may persist throughout a person’s life without causing any symptoms. The strength of the body’s immune response determines whether an infection is arrested here or progresses to the next stage. In healthy people, the infection may be stopped permanently at this point. The granulomas subsequently heal, leaving small calcified lesions.
  • On the other hand, if the immune system is compromised by immunosuppressive drugs, HIV infections, malnutrition, aging, or other factors, the bacteria can be re-activated, replicate, escape from the granuloma and spread to other parts of the lungs causing active pulmonary tuberculosis. This reactivation may occur months or even years after the initial infection.
101
Q

In some cases, the bacteria may also spread to other organs of the body via the lymphatic system or the bloodstream

A

This widespread form of TB disease, called disseminated TB or
miliary TB, occurs most commonly in the very young, the very old and those with HIV infections.

102
Q

Tuberculosis is generally treatable with antibiotics. Several antibiotics are usually prescribed for many months due to the slow growth rate of the bacteria.

A

It’s very important that the patients complete the course of the treatment to prevent development of drug-resistant bacteria and re-occurrence of the disease.

103
Q

TB diagnosis

A
  • Rapid molecular test detecting presence of DNA
  • Microscopical examination of sputum for bacteria
  • Chest X-ray
  • Long term culture of bacteria [up to 12 weeks]
  • Skin test- [purified protein derivative/ tuberculin skin test] inject PPT into the skin which is prepared from dead TB bacteria. If a swelling appears at the injection site after 48-72 hours, then it is positive for TB.
104
Q

TB vaccine and treatment

A

BCG- [Bacillus Calmette–Guérin vaccine]- a weak attenuated [made harmless] form. One dose at the time of birth
* DOTS – [Direct Observable Treatment, short course] health worker or family member make sure that medicines are taken regularly for six to eight months.
* The drug widely used are isoniazid, rifampicin [in combination with other drugs like INH and pyrazinamide to avoid antibiotic resistance], ethambutol [in combination with other drugs like INH and rifampin to minimize resistance], pyrazinamide, etc
* Streptomycin was the first antibiotic to be discovered that was effective against the pathogen that causes tuberculosis. Streptomycin causes the death of the pathogen by binding to ribosomes and inhibiting protein synthesis

105
Q

Drug-resistant TB

A

Drug-resistant TB can occur when the drugs used to treat TB are misused or mismanaged.
Examples of misuse or mismanagement include:
 People do not complete a full course of TB treatment
 Health care providers prescribe the wrong treatment (the wrong dose or length of time)
 Drugs for proper treatment are not available
 Drugs are of poor quality

106
Q

Drug-resistant TB is more common in people who

A

 Do not take their TB drugs regularly
 Do not take all of their TB drugs
 Develop TB disease again, after being treated for TB disease in the past
 Come from areas of the world where drug-resistant TB is common
 Have spent time with someone known to have drug-resistant TB disease

107
Q

Mutation is a

A

random event and occurs with a frequency of about one in every thousand bacteria.

108
Q

People who do not complete a course of treatment are

A

highly likely to infect others with drug-resistant forms of TB

109
Q

DOTS (direct observation treatment

A

short course) involves health workers or responsible
family members making sure that patients take their medicine regularly for six to eight months.

110
Q

Multiple-drug-resistant

A

forms of TB (MDR-TB) now exist. These strains are resistant to at least
the two main drugs used to treat TB – isoniazid and rifampicin – which are known as first-line drugs.

111
Q

Extensively (or extremely) drug-resistant TB (XDR-TB)

A

has also emerged as a very serious threat to health, especially for those people who are HIV-positive . XDR-TB strains are resistant to first-line drugs and to the drugs used to treat MDR-TB.

112
Q

Why antibiotic is necessary for TB

A

 Bacteria that causes TB enter cells in lungs and hide from immune system. So antibiotics are given to kill / destroy / reduce the growth of bacteria.
 To make sure that all bacteria are killed
 To prevent the bacteria leaving the reservoir of infection [NOTE: Reservoir of infection: Any person, animal, plant, soil or substance in which an infectious agent normally lives and multiplies]
 To prevent death
 Inhibit protein synthesis
 Does not affect human cells

113
Q

Why TB has not been eradicated even though a vaccine has
existed since 1921?

A

*Vaccine [BCG] does not always give lasting protection or effectiveness decreases with years unless exposure to TB
*No worldwide vaccination programs like the one we had for smallpox
*Many are symptomless carriers
*Bacteria remain in the body for a long time and become active anytime
*Bacteria or parasite lives inside the cells or intracellular
*Lack of protein in the diet so less antibodies are produced
*Difficult to produce herd immunity

114
Q

Why TB has a greater impact on the health of people in some regions rather than others?

A
  • TB is the disease of the poverty that means people living in overcrowding conditions prone to get the disease
  • TB is also an opportunistic disease i.e., disease that occur more often or are more severe in people with weakened immune systems than in people with healthy immune systems. HIV weakens the immune system.
  • Vaccination programs for TB are better in some countries/ region than others
115
Q

Suggest how this drug resistance may have arisen in TB

A

 Patient does not complete course or takes inadequate dose or stop taking when feels better, so not all bacteria are killed. Remaining bacteria develop resistance to the antibiotics. These resistant strains survive, and multiply.
 Drug resistance can also occurs as a result of mutation in the bacterial DNA.
 May be continuous supply of antibiotic is not available
 Drug resistance might increase if only one type of antibiotic is used
 Changes in bacteria and host cells membrane structure also increases the chances of drug resistance in bacteria

116
Q

Treatment with four different antibiotics for TB

A

 increases chances of, killing all bacteria ;
 if bacteria are resistant to one antibiotic, then still susceptible to other antibiotics
 reduces chance of mutations arising / (if bacteria susceptible) mutations unlikely to occur against all antibiotics ;
 Antibiotic can be stopped because of side effects
 idea that more effective because different antibiotics will work on different targets (in the bacteria)

117
Q

random mutations in dna allow

A

some bacteria to be resistant (antibiotics dont
CAUSE mutations in bacterial dna)

118
Q

antibiotic usage + resistance

A

a narrow spectrum antibiotic shud be when u confirm know what
bacteria causes that disease
a broad spectrum is used when ydk what pathogen causes the disease
if you use one for the other’s purpose, it leads to antibiotic resistance
ans to this question is A

119
Q

not all mutations lead to

A

resistance

120
Q

the proportion of antibiotic-resistant bacteria in a population only increases if

A

the antibiotic is used!

121
Q

malaria cannot be passed from

A

human to human !

122
Q

Disease

A
  1. ill-health / absence of well-being / abnormal condition / AW, (affecting an organism) ;
  2. reduced effectiveness of, functions / named function ; AW
  3. (illness with a set of) symptoms ; AW A signs
  4. poor / AW, physical, mental or social, well-being ; A two out of the three
123
Q

Describe how TB is transmitted from infected to uninfected people.

A
  1. (infected) person, sneezes/coughs/sputum/spitting/breathes out;
  2. aerosol/droplets, in the air/moist air, inhaled/breathed in by (uninfected person);
124
Q

Non-infectious disease

A
  1. not transmissible from one person to another / AW ;
  2. not caused by a pathogen ; R bacterium / virus / fungus / AW / ‘worm’
125
Q

Reason for increase in the cases of TB in developed countries now:

A
  1. development of antibiotic resistance (by organism) ; A drug resistance R immunity
  2. ref. impact of HIV infection ;
  3. higher rate of immigration from countries with high incidence / AW ;
  4. increase in tourism to countries with high incidence ;
  5. reduced surveillance leading to undetected cases (and hence spread) ;
  6. (detected cases, MDR) unwillingness / AW, to maintain drug regimen / AW ;
  7. ref. to vaccination programmes no longer taking place ;
  8. ref. to poor / overcrowded, housing (in cities) / AW ; must be in context of developed countries
126
Q

Discuss the biological and social factors which make TB a difficult disease to control
7 factors

A
  • TRANSMISSION
    -HIV/IMMUNODEFICIENCY
    -DIAGNOSIS IS DIFFICULT
    -TREATMENT
  • ACQUIRED RESISTANCE
    -VACCINATION
    -EDUCATION
127
Q

transmission of TB

A

Eg. aerosol, droplet infection
overcrowded, housing / living conditions / AW
migration / travel, from areas with high rates of TB
reservoir of infection in people not, diagnosed / not treated

128
Q

HIV / immunodeficiency of TB

A

e.g. infection with HIV may activate (dormant) TB (pathogen)
immunodeficiency / AW, makes people more susceptible to TB
intravenous drug taking increases risk of, immunodeficiency / HIV

129
Q

diagnosis is difficult of TB

A

e.g. TB (pathogen) remains dormant / symptomless carriers
limited access to health care for diagnosis / AW
idea that contact tracing is difficult

130
Q

treatment of TB

A

e.g. treatment is long term / treatment may not start early enough
people may not finish the course of treatment
limited access to health care for treatment

131
Q

acquired resistance of TB

A

e.g. bacterium / TB (pathogen), develops resistance to, antibiotic(s) / drug(s)
multi-drug resistance / MDR-TB / XDR-TB

132
Q

vaccination of TB

A

e.g. vaccine may not always be effective in providing protection
difficult to achieve herd immunity
concerns / misconceptions, about vaccination
limited access to vaccination (programmes)
poor (immune) response in people who are malnourished
poor thermostability of vaccine

133
Q

educationof TB

A

e.g. limited education / low awareness, about prevention for general population
limited education / low awareness, for health care professionals

134
Q

Transmission of HIV:

A
  1. Sexual intercourse;
  2. Infected, blood/blood products;
  3. Sharing/re-using, hypodermic needles;
  4. Across placenta/from mother to foetus;
  5. Breast milk;
135
Q

Explain why cholera remains a significant infectious disease in some parts of the world.

A
  1. poor sanitation / no treatment of faecal waste;
  2. contamination of (drinking) water supply;
  3. poverty / poor living conditions / poor hygiene / poor (health) education;
  4. ref to natural disasters; e.g. assistance / aid / medical help / AW, cannot arrive in time
  5. no rehydration therapy available (at time when needed);
  6. no (effective) vaccine;
  7. further detail; (bacteria live in gut, where immune system is not effective)
136
Q

Describe the methods of prevention of cholera.

A

ref. to treat drinking water ; A clean / sterilised / chlorinated / safe / bottled / boiled A ref. to water treatment plants
provide sewage treatment plants ; A treat waste water / containment of sewage / provide latrines (in temporary camps) ;
ref. to keeping sewage and (drinking) water sources separate ; A examples e.g. avoid swimming downstream of sewage outlets avoid defecating near rivers used for washing water treatment plants upstream of sewage disposal bury faeces
ref. to vaccination / providing vaccines ;
ref. to education in ways to prevent spread ;
ref. to (encourage) hand washing ;
ref. to food hygiene ; e.g. use of clean cooking utensils / covering food to prevent flies landing / washing food in treated water / cook food thoroughly / peel fruit and vegetable washed in (suspected) contaminated water
discourage use of human faeces for fertiliser / use fertiliser other than human faeces / do not irrigate plant food with contaminated water;
control breeding of, vectors / flies ;
rapid diagnosis ;
rapid treatment (for earlier recovery to minimise risk of spreading) ;
ref. to oral rehydration, salts / therapy ;
use of antibiotics ;
ref. to isolation / quarantine ;

137
Q

Explain why it is recommended that antibiotics should not be given as a preventative to cholera or to treat mild cases of cholera

A

Oral rehydration therapy is effective to treat cholera
ORS is a solution of glucose and salts which help rehydrate the body
Antibiotics can act as a selection pressure
Ref. to antibiotic resistance developed
Transmission of resistance by [vertical or horizontal transmission] (not in 2022 syllabus) AVP. through plasmid or through binary fission of bacteria
Antibiotics will become less effective
And so should only be used as a last resort
Ref. to cost
Antibiotics will also kill gut bacteria
Idea that it will disrupt the gut function
AVP. antibiotics can cause mutations etc.

138
Q

Explain why vaccination programs have not be able to eradicate malaria

A

pathogen
(because) four / several, different, causative species / AW, (with different antigens) ;
(pathogen has) many antigens as it is eukaryotic / many genes coding for antigens ;
ref. to mutation changing antigens ;
pathogen has different stages of life cycle (within human) with different antigens ;
I ref. to antigenic shift
antigenic concealment / pathogen spends part of life cycle within host cells / AW ;
A short time in blood plasma

vaccine
ref. to more than one type of vaccine needed ;
suggestion that antigens used have not given the strongest immune response ;

vaccination programme
ref. to only trial programmes ;
A programmes not global
ref. to not achieving herd immunity / not enough people (successfully) vaccinated ;
detail ;
e.g. lack of willingness to be vaccinated
lack of trained people to give vaccines
poor nutrition and poor immune response

139
Q

Discuss the reasons why vaccination has not eradicated cholera and sickle cell anaemia.
cholera up to max 4

A

cholera up to max 4
1 transmission cycle is difficult to break; A described with example(s)
2 ref. difficulty in administering e.g. refugee camp, displaced, disaster ;
3 poor diet, lowered immune response ;
4 more than one strain (needs more than one type of vaccine) ; A more than one
type (that causes cholera) R constantly mutating
5 vaccine, only gives short-term protection / requiring boosters ;
6 antigenic concealment ;
7 qualified ; e.g. organism in intestines, difficult for antibodies to reach
8 ref. (older or newer oral) vaccine, not successful for everyone / variable (60–65% up
to 90% depending on population group) protection ;
9 no requirement by health authorities (for vaccine) / vaccine not used by health
authorities ; AW
sickle cell
1 no vaccine available ; A cannot vaccinate against sickle cell
2 not caused by pathogen / non-infectious / non-transmissible / non-communicable ;
3 genetic / inherited, disease / AW ; A caused by a mutation
4 affects all red blood cells so vaccine would lead to their destruction ;

140
Q

Outline how a vaccine can protect against xyz

A

Vaccine contains antigens
Primary immune response occurs
B-lymphocytes undergo clonal selection. Only specific B cells with receptors complementary to antigen will be activated
These cells divide by mitosis (clonal expansion) to develop into plasma cells
which secrete antibodies
Production of memory cells
T-helper cells secrete cytokines
Cytokines stimulate specific B-cells/ macrophages/ killer T-cells / increases humoral response
Secondary immune response is much faster
Higher level antibodies are produced during reinfection
This gives artificial active immunity

141
Q

Explain how resistance to drugs such as rifampicin develops

A

Overuse of antibiotics or misuse of antibiotics eg. taking antibiotics for viral infections, overprescribing for bacterial infections
not completing an antibiotic course
Reservoir of bacteria remains
Ref to mutation (i wrote, antibiotic acts as a selection pressure and induces a mutation in bacteria which makes it resistant)
Any detail of mutation eg. protein produced as a changed binding site
Bacteria with resistance survive or only bacteria sensitive to antibiotic are killed A antibiotic acts as a selection pressure
Bacteria reproduce and pass on gene/allele for resistance to offspring or [vertical transmission] (not in 2022 syllabus)
Frequency of resistance alleles/gene increase in bacterial population

142
Q
A